{
    "xml": "<topic id=\"PHP2522\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/cyclizine\" basename=\"cyclizine\" title=\"CYCLIZINE\">\n<title>CYCLIZINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_329\" namespace=\"/interactions/list-of-drug-interactions/antihistamines/antihistamines-sedating/cyclizine\">Cyclizine</xref>\n</p>\n<data name=\"vtmid\">85354008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_225690438\" title=\"Antihistamines\">Antihistamines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP52218\" outputclass=\"indicationsAndDose\" rev=\"1.28\" parent=\"/drugs/cyclizine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nausea</p>\n<p outputclass=\"therapeuticIndication\">Vomiting</p>\n<p outputclass=\"therapeuticIndication\">Vertigo</p>\n<p outputclass=\"therapeuticIndication\">Motion sickness</p>\n<p outputclass=\"therapeuticIndication\">Labyrinthine disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg up to 3 times a day, for motion sickness, take 1&#8211;2 hours before departure.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg 3 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nausea and vomiting of known cause</p>\n<p outputclass=\"therapeuticIndication\">Nausea and vomiting associated with vestibular disorders and palliative care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;5 years</p>\n<p>0.5&#8211;1&#8239;mg/kg up to 3 times a day (max. per dose 25&#8239;mg), intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>25&#8239;mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>50&#8239;mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By rectum</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;5 years</p>\n<p>12.5&#8239;mg up to 3 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>25&#8239;mg up to 3 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>50&#8239;mg up to 3 times a day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By continuous intravenous infusion or by subcutaneous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>3&#8239;mg/kg, dose to be given over 24 hours.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;4 years</p>\n<p>50&#8239;mg, dose to be given over 24 hours.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>75&#8239;mg, dose to be given over 24 hours.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>150&#8239;mg, dose to be given over 24 hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nausea and vomiting associated with palliative care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8239;mg, dose to be given over 24 hours.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg up to 3 times a day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52062\" outputclass=\"unlicensedUse\" rev=\"1.11\" parent=\"/drugs/cyclizine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Tablets not licensed for use in children under 6 years.</p>\n<p>Injection not licensed for use in children.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52342\" outputclass=\"contraindications\" rev=\"1.15\" parent=\"/drugs/cyclizine\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref> (some antihistamines are thought to be safe)</ph>; <ph outputclass=\"contraindication\">neonate (due to significant antimuscarinic activity)</ph> (in neonates)</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP52372\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/cyclizine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Epilepsy</ph>; <ph outputclass=\"caution\">glaucoma</ph> (in children); <ph outputclass=\"caution\">may counteract haemodynamic benefits of opioids</ph>; <ph outputclass=\"caution\">neuromuscular disorders&#8212;increased risk of transient paralysis with intravenous use</ph>; <ph outputclass=\"caution\">prostatic hypertrophy</ph> (in adults); <ph outputclass=\"caution\">pyloroduodenal obstruction</ph>; <ph outputclass=\"caution\">severe heart failure&#8212;may cause fall in cardiac output and associated increase in heart rate, mean arterial pressure and pulmonary wedge pressure</ph>; <ph outputclass=\"caution\">susceptibility to angle-closure glaucoma</ph> (in adults); <ph outputclass=\"caution\">urinary retention</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52190\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/cyclizine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (antihistamines).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52113\" outputclass=\"sideEffects\" rev=\"1.32\" parent=\"/drugs/cyclizine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Drowsiness</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaphylaxis</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">angle-closure glaucoma</ph>; <ph outputclass=\"sideEffect\">arrhythmias</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">extrapyramidal effects</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">liver dysfunction</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">paradoxical stimulation (especially with high doses in children)</ph> (in children); <ph outputclass=\"sideEffect\">paradoxical stimulation (especially with high doses in the elderly)</ph> (in adults); <ph outputclass=\"sideEffect\">photosensitivity reactions</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">sleep disturbances</ph>; <ph outputclass=\"sideEffect\">tremor</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Antimuscarinic effects</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">movement disorders</ph>; <ph outputclass=\"sideEffect\">oculogyric crisis</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">psychomotor impairment</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">transient speech disorders</ph>; <ph outputclass=\"sideEffect\">twitching</ph>; <ph outputclass=\"sideEffect\">urinary retention</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">transient paralysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With subcutaneous use</p>\n<p>\n<ph outputclass=\"sideEffect\">local irritation</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Elderly patients are more susceptible to side-effects.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Children are more susceptible to side-effects.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely, especially with high doses or in children and the elderly. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely in children, especially with high doses. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52170\" outputclass=\"pregnancy\" parent=\"/drugs/cyclizine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid; however, there is no evidence of teratogenicity.</p>\n<p>The use of sedating antihistamines in the latter part of the third trimester may cause adverse effects in neonates such as irritability, paradoxical excitability, and tremor.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52410\" outputclass=\"breastFeeding\" parent=\"/drugs/cyclizine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available.</p>\n<p>Most antihistamines are present in breast milk in varying amounts; although not known to be harmful, most manufacturers advise avoiding their use in mothers who are breast-feeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52283\" outputclass=\"hepaticImpairment\" parent=\"/drugs/cyclizine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe liver disease&#8212;increased risk of coma.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52450\" outputclass=\"directionsForAdministration\" rev=\"1.21\" parent=\"/drugs/cyclizine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>For administration <i>by mouth</i>, tablets may be crushed.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p outputclass=\"title\">Mixing and compatibility for the use of syringe drivers in palliative care</p>\n<p>Cyclizine may precipitate at concentrations above 10&#8239;mg/mL or in the presence of sodium chloride 0.9% <i>or</i> as the concentration of diamorphine relative to cyclizine increases; mixtures of diamorphine and cyclizine are also likely to precipitate after 24 hours.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52158\" outputclass=\"patientAndCarerAdvice\" rev=\"1.10\" parent=\"/drugs/cyclizine\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\n<title>Driving and skilled tasks</title>\n<sectiondiv>\n<p>Drowsiness may affect performance of skilled tasks (e.g. cycling, driving); effects of alcohol enhanced.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2522-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/cyclizine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: suppository, oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77657\" title=\"Tablet\" namespace=\"/drugs/cyclizine/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77652\" title=\"Solution for injection\" namespace=\"/drugs/cyclizine/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85588\" namespace=\"/drugs/cyclizine-with-morphine\" title=\"CYCLIZINE WITH MORPHINE\" count=\"1\" rel=\"backlink\">CYCLIZINE WITH MORPHINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP92544\" namespace=\"/drugs/ergotamine-tartrate-with-caffeine-hydrate-and-cyclizine-hydrochloride\" title=\"ERGOTAMINE TARTRATE WITH CAFFEINE HYDRATE AND CYCLIZINE HYDROCHLORIDE\" count=\"1\" rel=\"backlink\">ERGOTAMINE TARTRATE WITH CAFFEINE HYDRATE AND CYCLIZINE HYDROCHLORIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"2\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78111\" namespace=\"/treatment-summaries/antihistamines-allergen-immunotherapy-and-allergic-emergencies\" title=\"Antihistamines, allergen immunotherapy and allergic emergencies\" count=\"2\" rel=\"backlink\">Antihistamines, allergen immunotherapy and allergic emergencies</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78144\" namespace=\"/treatment-summaries/acute-coronary-syndromes\" title=\"Acute coronary syndromes\" count=\"1\" rel=\"backlink\">Acute coronary syndromes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78221\" namespace=\"/treatment-summaries/nausea-and-labyrinth-disorders\" title=\"Nausea and labyrinth disorders\" count=\"2\" rel=\"backlink\">Nausea and labyrinth disorders</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_329\" namespace=\"/interactions/list-of-drug-interactions/antihistamines/antihistamines-sedating/cyclizine\" title=\"Cyclizine\" count=\"1\" rel=\"link\">Cyclizine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77657\" namespace=\"/drugs/cyclizine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77652\" namespace=\"/drugs/cyclizine/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP2522",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/cyclizine",
    "basename": "cyclizine",
    "title": "CYCLIZINE",
    "interactants": [
        {
            "id": "bnf_int_329",
            "label": "Cyclizine"
        }
    ],
    "vtmid": "85354008",
    "drugClassification": [
        "Antihistamines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Nausea",
                        "html": "Nausea"
                    },
                    {
                        "textContent": "Vomiting",
                        "html": "Vomiting"
                    },
                    {
                        "textContent": "Vertigo",
                        "html": "Vertigo"
                    },
                    {
                        "textContent": "Motion sickness",
                        "html": "Motion sickness"
                    },
                    {
                        "textContent": "Labyrinthine disorders",
                        "html": "Labyrinthine disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intramuscular injection"
                    ],
                    "textContent": "By intravenous injection or by intramuscular injection",
                    "html": "By intravenous injection or by intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "50 mg up to 3 times a day, for motion sickness, take 1&#8211;2 hours before departure.",
                        "html": "<p>50&#8239;mg up to 3 times a day, for motion sickness, take 1&#8211;2 hours before departure.</p>"
                    },
                    {
                        "textContent": "50 mg 3 times a day.",
                        "html": "<p>50&#8239;mg 3 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nausea and vomiting of known cause",
                        "html": "Nausea and vomiting of known cause"
                    },
                    {
                        "textContent": "Nausea and vomiting associated with vestibular disorders and palliative care",
                        "html": "Nausea and vomiting associated with vestibular disorders and palliative care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous intravenous infusion or subcutaneous infusion"
                    ],
                    "textContent": "By continuous intravenous infusion or by subcutaneous infusion",
                    "html": "By continuous intravenous infusion or by subcutaneous infusion"
                },
                "child": [
                    {
                        "textContent": "0.5&#8211;1 mg/kg up to 3 times a day (max. per dose 25 mg), intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.",
                        "html": "<p>0.5&#8211;1&#8239;mg/kg up to 3 times a day (max. per dose 25&#8239;mg), intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>",
                        "ageGroup": "1 month&#8211;5 years"
                    },
                    {
                        "textContent": "25 mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.",
                        "html": "<p>25&#8239;mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "50 mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.",
                        "html": "<p>50&#8239;mg up to 3 times a day, intravenous injection to be given over 3&#8211;5 minutes, for motion sickness, take 1&#8211;2 hours before departure.</p>",
                        "ageGroup": "12&#8211;17 years"
                    },
                    {
                        "textContent": "12.5 mg up to 3 times a day.",
                        "html": "<p>12.5&#8239;mg up to 3 times a day.</p>",
                        "ageGroup": "2&#8211;5 years"
                    },
                    {
                        "textContent": "25 mg up to 3 times a day.",
                        "html": "<p>25&#8239;mg up to 3 times a day.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "50 mg up to 3 times a day.",
                        "html": "<p>50&#8239;mg up to 3 times a day.</p>",
                        "ageGroup": "12&#8211;17 years"
                    },
                    {
                        "textContent": "3 mg/kg, dose to be given over 24 hours.",
                        "html": "<p>3&#8239;mg/kg, dose to be given over 24 hours.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "50 mg, dose to be given over 24 hours.",
                        "html": "<p>50&#8239;mg, dose to be given over 24 hours.</p>",
                        "ageGroup": "2&#8211;4 years"
                    },
                    {
                        "textContent": "75 mg, dose to be given over 24 hours.",
                        "html": "<p>75&#8239;mg, dose to be given over 24 hours.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "150 mg, dose to be given over 24 hours.",
                        "html": "<p>150&#8239;mg, dose to be given over 24 hours.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nausea and vomiting associated with palliative care",
                        "html": "Nausea and vomiting associated with palliative care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "150 mg, dose to be given over 24 hours.",
                        "html": "<p>150&#8239;mg, dose to be given over 24 hours.</p>"
                    },
                    {
                        "textContent": "50 mg up to 3 times a day.",
                        "html": "<p>50&#8239;mg up to 3 times a day.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Tablets not licensed for use in children under 6 years.\n\nInjection not licensed for use in children.",
                "html": "<p>Tablets not licensed for use in children under 6 years.</p><p>Injection not licensed for use in children.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid in Acute porphyrias (some antihistamines are thought to be safe)",
                "html": "Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref> (some antihistamines are thought to be safe)",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "neonate (due to significant antimuscarinic activity) in neonates",
                "html": "neonate (due to significant antimuscarinic activity) in neonates",
                "specificity": {
                    "patientType": "neonates"
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Epilepsy",
                "html": "Epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "glaucoma in children",
                "html": "glaucoma in children",
                "specificity": {
                    "patientType": "children"
                }
            },
            {
                "type": "cautions",
                "textContent": "may counteract haemodynamic benefits of opioids",
                "html": "may counteract haemodynamic benefits of opioids"
            },
            {
                "type": "cautions",
                "textContent": "neuromuscular disorders&#8212;increased risk of transient paralysis with intravenous use",
                "html": "neuromuscular disorders&#8212;increased risk of transient paralysis with intravenous use"
            },
            {
                "type": "cautions",
                "textContent": "prostatic hypertrophy in adults",
                "html": "prostatic hypertrophy in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "pyloroduodenal obstruction",
                "html": "pyloroduodenal obstruction"
            },
            {
                "type": "cautions",
                "textContent": "severe heart failure&#8212;may cause fall in cardiac output and associated increase in heart rate, mean arterial pressure and pulmonary wedge pressure",
                "html": "severe heart failure&#8212;may cause fall in cardiac output and associated increase in heart rate, mean arterial pressure and pulmonary wedge pressure"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to angle-closure glaucoma in adults",
                "html": "susceptibility to angle-closure glaucoma in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "urinary retention",
                "html": "urinary retention"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (antihistamines).",
                "html": "<p>Appendix 1 (antihistamines).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Drowsiness",
                        "html": "Drowsiness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Anaphylaxis",
                        "html": "Anaphylaxis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angle-closure glaucoma",
                        "html": "angle-closure glaucoma",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "arrhythmias",
                        "html": "arrhythmias",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "extrapyramidal effects",
                        "html": "extrapyramidal effects",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "liver dysfunction",
                        "html": "liver dysfunction",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "paradoxical stimulation (especially with high doses in children) in children",
                        "html": "paradoxical stimulation (especially with high doses in children) in children",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare",
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "paradoxical stimulation (especially with high doses in the elderly) in adults",
                        "html": "paradoxical stimulation (especially with high doses in the elderly) in adults",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare",
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "photosensitivity reactions",
                        "html": "photosensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "sleep disturbances",
                        "html": "sleep disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Antimuscarinic effects",
                        "html": "Antimuscarinic effects",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal disturbances",
                        "html": "gastro-intestinal disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "movement disorders",
                        "html": "movement disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oculogyric crisis",
                        "html": "oculogyric crisis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "psychomotor impairment",
                        "html": "psychomotor impairment",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "transient speech disorders",
                        "html": "transient speech disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "twitching",
                        "html": "twitching",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urinary retention",
                        "html": "urinary retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "transient paralysis",
                        "html": "transient paralysis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "local irritation",
                        "html": "local irritation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Elderly patients are more susceptible to side-effects.",
                "html": "<p>Elderly patients are more susceptible to side-effects.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Children are more susceptible to side-effects.",
                "html": "<p>Children are more susceptible to side-effects.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely, especially with high doses or in children and the elderly. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.",
                "html": "<p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely, especially with high doses or in children and the elderly. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely in children, especially with high doses. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.",
                "html": "<p>Drowsiness is a significant side-effect with most of the older antihistamines although paradoxical stimulation may occur rarely in children, especially with high doses. Drowsiness may diminish after a few days of treatment and is considerably less of a problem with the newer antihistamines.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid; however, there is no evidence of teratogenicity.\n\nThe use of sedating antihistamines in the latter part of the third trimester may cause adverse effects in neonates such as irritability, paradoxical excitability, and tremor.",
                "html": "<p>Manufacturer advises avoid; however, there is no evidence of teratogenicity.</p><p>The use of sedating antihistamines in the latter part of the third trimester may cause adverse effects in neonates such as irritability, paradoxical excitability, and tremor.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available.\n\nMost antihistamines are present in breast milk in varying amounts; although not known to be harmful, most manufacturers advise avoiding their use in mothers who are breast-feeding.",
                "html": "<p>No information available.</p><p>Most antihistamines are present in breast milk in varying amounts; although not known to be harmful, most manufacturers advise avoiding their use in mothers who are breast-feeding.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe liver disease&#8212;increased risk of coma.",
                "html": "<p>Avoid in severe liver disease&#8212;increased risk of coma.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "For administration by mouth, tablets may be crushed.",
                "html": "<p>For administration <i>by mouth</i>, tablets may be crushed.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "subcutaneous"
                    ]
                },
                "title": "Mixing and compatibility for the use of syringe drivers in palliative care",
                "textContent": "Cyclizine may precipitate at concentrations above 10 mg/mL or in the presence of sodium chloride 0.9% or as the concentration of diamorphine relative to cyclizine increases; mixtures of diamorphine and cyclizine are also likely to precipitate after 24 hours.",
                "html": "<p>Cyclizine may precipitate at concentrations above 10&#8239;mg/mL or in the presence of sodium chloride 0.9% <i>or</i> as the concentration of diamorphine relative to cyclizine increases; mixtures of diamorphine and cyclizine are also likely to precipitate after 24 hours.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "textContent": "Drowsiness may affect performance of skilled tasks (e.g. cycling, driving); effects of alcohol enhanced.",
                "html": "<p>Drowsiness may affect performance of skilled tasks (e.g. cycling, driving); effects of alcohol enhanced.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "suppository",
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77657",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77652",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85588",
                "label": "CYCLIZINE WITH MORPHINE",
                "type": "drug"
            },
            {
                "id": "PHP92544",
                "label": "ERGOTAMINE TARTRATE WITH CAFFEINE HYDRATE AND CYCLIZINE HYDROCHLORIDE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78111",
                "label": "Antihistamines, allergen immunotherapy and allergic emergencies",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78144",
                "label": "Acute coronary syndromes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78221",
                "label": "Nausea and labyrinth disorders",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_329",
                "label": "Cyclizine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77657",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77652",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}